RxDoctor Payments Data

Zachary Borab, MD

Plastic and Reconstructive Surgery · Manasquan, NJNPI 1619401866

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 76.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $756 and has fallen 54.3% since, to $346 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in NJ, where the typical reported total is $1,513.

$1,391in general payments, 2019–2025

Across 21 payments — averaging $66.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Integra Lifesciences Corporation$163
  • Convatec Inc.$62
  • TELA Bio, Inc.$54
  • Musculoskeletal Transplant Foundation Inc.$27
  • Motiva USA, LLC$15
$996in research payments, 2019–2025

Across 3 payments — averaging $332.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$996

What the payments were for

  • Food & beverage$1,391100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,391 in reported general payments places this provider in the 45th percentile of 93 plastic and reconstructive surgery providers in New Jersey.

See all plastic and reconstructive surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$23,255
Medicare patients
35
Services billed
93

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Manasquan

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →